QTTB
Income statement / Annual
Last year (2023), Q32 Bio Inc.'s total revenue was $1.16 M,
a decrease of 82.62% from the previous year.
In 2023, Q32 Bio Inc.'s net income was -$112.96 M.
See Q32 Bio Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$1.16 M
|
$6.65 M
|
$33.97 M
|
$2.70 M
|
$1.67 M
|
$5.32 M
|
$0.00
|
$0.00
|
| Cost of Revenue |
$578,000.00 |
$2.60 M |
$9.54 M |
$0.00 |
$0.00 |
$0.00 |
$684,214.00 |
$239,797.00 |
| Gross Profit |
$578,000.00 |
$4.05 M |
$24.43 M |
$2.70 M |
$1.67 M |
$5.32 M |
-$684,214.00 |
-$239,797.00 |
| Gross Profit Ratio |
0.5 |
0.61 |
0.72 |
1 |
1 |
1 |
0 |
0 |
| Research and Development
Expenses |
$62.00 M
|
$35.81 M
|
$29.93 M
|
$100.39 M
|
$89.40 M
|
$47.95 M
|
$21.38 M
|
$5.69 M
|
| General & Administrative
Expenses |
$0.00
|
$10.06 M
|
$6.76 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$30.68 M
|
$10.06 M
|
$6.76 M
|
$23.67 M
|
$15.89 M
|
$16.01 M
|
$7.60 M
|
$4.07 M
|
| Other Expenses |
$0.00 |
-$1.12 M |
-$324,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$92.68 M |
$45.88 M |
$36.69 M |
$124.06 M |
$105.29 M |
$63.96 M |
$28.97 M |
$9.76 M |
| Cost And Expenses |
$93.26 M |
$45.88 M |
$36.69 M |
$132.97 M |
$111.61 M |
$65.25 M |
$29.66 M |
$10.00 M |
| Interest Income |
$5.58 M |
$0.00 |
$0.00 |
$1.57 M |
$6.03 M |
$4.35 M |
$542,635.00 |
$24,201.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$578,000.00
|
$2.60 M
|
$9.54 M
|
$8.90 M
|
$6.32 M
|
$1.29 M
|
$684,214.00
|
$239,797.00
|
| EBITDA |
-$86.50 M
|
-$38.86 M
|
-$86.22 M
|
-$121.36 M
|
-$103.63 M
|
-$58.64 M
|
-$29.31 M
|
-$7.81 M
|
| EBITDA Ratio |
-74.83 |
-5.48 |
-1.08 |
-44.91 |
-62.2 |
-11.02 |
0 |
0 |
| Operating Income Ratio
|
-79.67
|
-5.9
|
-1.08
|
-48.21
|
-65.99
|
-11.26
|
0
|
0
|
| Total Other
Income/Expenses Net |
$5.02 M
|
-$3.52 M
|
-$324,000.00
|
$1.57 M
|
$6.03 M
|
$4.35 M
|
-$333,365.00
|
$1.95 M
|
| Income Before Tax |
-$87.08 M |
-$42.75 M |
-$37.02 M |
-$128.69 M |
-$103.92 M |
-$55.58 M |
-$29.99 M |
-$8.05 M |
| Income Before Tax Ratio
|
-75.33
|
-6.43
|
-1.09
|
-47.63
|
-62.37
|
-10.44
|
0
|
0
|
| Income Tax Expense |
$25.88 M |
$62,000.00 |
$547,000.00 |
-$1.00 |
$0.00 |
$0.00 |
-$4.00 |
$2.00 |
| Net Income |
-$112.96 M |
-$42.81 M |
-$37.56 M |
-$128.69 M |
-$103.92 M |
-$55.58 M |
-$29.99 M |
-$8.05 M |
| Net Income Ratio |
-97.72 |
-6.44 |
-1.11 |
-47.63 |
-62.37 |
-10.44 |
0 |
0 |
| EPS |
-35.16 |
-13.42 |
-12.23 |
-50.46 |
-44.41 |
-35.04 |
-14.42 |
-3.87 |
| EPS Diluted |
-35.16 |
-13.42 |
-12.23 |
-50.46 |
-44.41 |
-35.04 |
-14.42 |
-3.87 |
| Weighted Average Shares
Out |
$3.21 M
|
$3.19 M
|
$3.07 M
|
$2.55 M
|
$2.34 M
|
$1.59 M
|
$2.08 M
|
$2.08 M
|
| Weighted Average Shares
Out Diluted |
$3.21 M
|
$3.19 M
|
$3.07 M
|
$2.55 M
|
$2.34 M
|
$1.59 M
|
$2.08 M
|
$2.08 M
|
| Link |
|
|
|
|
|
|
|
|
